RNA interference suppression of mucin 5AC (MUC5AC) reduces the adhesive and invasive capacity of human pancreatic cancer cells

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, May 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

patent: 4 patents

Citations

dimensions_citation: 49 Dimensions

Readers on

mendeley: 19 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

IMMUNOTHERAPEUTIC TREATMENT OF CANCER

Application WO-2017125765-A1

World Intellectual Property Organisation (WIPO)

Pharmaceutical composition for treatment of cancer and asthma

Grant US-8389711-B2

United States of America

PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER AND ASTHMA

Application EP-2377934-A4

European Patent Office

PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER AND ASTHMA

Application EP-2377934-A1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.